TSHA
Taysha Gene Therapies Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.49
-0.12 ▼ -2.60%
🌙 3월 13일 5:16 PM ET (한국 3/14 06:16)
$4.39
-0.10 ▼ -2.23%
| Index | RUT | P/E | - | EPS (ttm) | -0.35 | Insider Own | 18.08% | Shs Outstand | 0.27B | Perf Week | -1.75% |
| Market Cap | 1.23B | Forward P/E | - | EPS next Y | -23.26% | Insider Trans | -1.92% | Shs Float | 0.22B | Perf Month | -3.65% |
| Enterprise Value | 1.00B | PEG | - | EPS next Q | -0.1 | Inst Own | 94.77% | Short Float | 22.14% | Perf Quarter | -19.24% |
| Income | -0.10B | P/S | 194.91 | EPS this Y | 0.09% | Inst Trans | 4.13% | Short Ratio | 18.04 | Perf Half Y | 38.58% |
| Sales | 0.01B | P/B | 5.62 | EPS next 5Y | -10.28% | ROA | -40.23% | Short Interest | 49.69M | Perf YTD | -18.36% |
| Book/sh | 0.8 | P/C | 4.13 | EPS past 3/5Y | 57.45% -63.99% | ROE | -64.93% | 52W High | -25.42% ($6.02) | Perf Year | 161.05% |
| Cash/sh | 1.09 | P/FCF | - | Sales past 3/5Y | - | ROIC | -34.89% | 52W Low | 327.62% ($1.05) | Perf 3Y | 376.09% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -945.72% | Gross Margin | 81.77% | Volatility(W/M) | 5.58% 5.33% | Perf 5Y | -83.4% |
| Dividend TTM | - | EV/Sales | 158.74 | Sales Y/Y TTM | -36.36% | Oper. Margin | -1618.54% | ATR (14) | 0.25 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 10.47 | EPS Q/Q | 2.83% | Profit Margin | -1583.66% | RSI (14) | 44.25 | Recom | 1.07 |
| Dividend Gr. 3/5Y | - | Current Ratio | 10.47 | Sales Q/Q | -100% | SMA20 | -2.71% ($4.62) | Beta | 1.08 | Target Price | $11 |
| Payout | - | Debt/Eq | 0.32 | Earnings | 3000000 | SMA50 | -5.05% ($4.73) | Rel Volume | 1.83 | Prev Close | $4.61 |
| Employees | 73 | LT Debt/Eq | 0.31 | EPS/Sales Surpr. | -1.01% -80.03% | SMA200 | 14.73% ($3.91) | Avg Volume(3M) | 2.75M | Price | $4.49 |
| IPO | 2020/9/24 | Option/Short | Yes/Yes | Trades | 14825 | Volume | 5,043,062 | Change | -2.6% |
뉴스 로딩 중...